In last trading session, Cytosorbents Corp (NASDAQ:CTSO) saw 0.15 million shares changing hands with its beta currently measuring 0.55. Company’s recent per share price level of $0.91 trading at $0.01 or 1.21% at ring of the bell on the day assigns it a market valuation of $49.77M. That closing price of CTSO’s stock is at a discount of -136.26% from its 52-week high price of $2.15 and is indicating a premium of 23.08% from its 52-week low price of $0.70. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.11 million shares which gives us an average trading volume of 115.02K if we extend that period to 3-months.
Cytosorbents Corp (NASDAQ:CTSO) trade information
Upright in the green during last session for gaining 1.21%, in the last five days CTSO remained trading in the red while hitting it’s week-highest on Monday, 11/25/24 when the stock touched $0.91 price level, adding 6.19% to its value on the day. Cytosorbents Corp’s shares saw a change of -18.00% in year-to-date performance and have moved -0.62% in past 5-day. Cytosorbents Corp (NASDAQ:CTSO) showed a performance of -10.76% in past 30-days. Number of shares sold short was 1.3 million shares which calculate 9.27 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cytosorbents Corp (CTSO) estimates and forecasts
Statistics highlight that Cytosorbents Corp is scoring comparatively higher than the scores of other players of the relevant industry. The company added 3.43% of value to its shares in past 6 months, showing an annual growth rate of 53.13% while that of industry is 11.50. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 5.99% from the last financial year’s standing.
3 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 9.45M for the same. And 2 analysts are in estimates of company making revenue of 10.09M in the next quarter. Company posted 8.67M and 9.79M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -2.64% during past 5 years.
Cytosorbents Corp (NASDAQ:CTSO)’s Major holders
Insiders are in possession of 3.82% of company’s total shares while institution are holding 33.46 percent of that, with stock having share float percentage of 34.79%. Investors also watch the number of corporate investors in a company very closely, which is 33.46% institutions for Cytosorbents Corp that are currently holding shares of the company. AVENIR CORP is the top institutional holder at CTSO for having 2.97 million shares of worth $2.09 million. And as of 2024-06-30, it was holding 5.4738 of the company’s outstanding shares.
The second largest institutional holder is SKYLANDS CAPITAL, LLC, which was holding about 2.84 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.2352 of outstanding shares, having a total worth of $2.0 million.
